{"id":"aminoacridine","rwe":[],"tags":[{"label":"aminoacridine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Ribosyldihydronicotinamide dehydrogenase [quinone]","category":"target"},{"label":"NQO2","category":"gene"},{"label":"MAOA","category":"gene"},{"label":"D08AA02","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Anti-Infective Agents, Local","category":"pharmacology"},{"label":"Coloring Agents","category":"pharmacology"},{"label":"Fluorescent Dyes","category":"pharmacology"},{"label":"Indicators and Reagents","category":"pharmacology"},{"label":"Luminescent Agents","category":"pharmacology"},{"label":"Mutagens","category":"pharmacology"},{"label":"Noxae","category":"pharmacology"}],"phase":"unknown","safety":{"commonSideEffects":[],"contraindications":["Anemia due to enzyme deficiency","Deficiency of glucose-6-phosphate dehydrogenase","Disease of blood AND/OR blood-forming organ","Disease of liver","Kidney disease","Porphyria"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:31:54.067558","allNames":"monacrin","offLabel":[],"synonyms":["aminacrine hydrochloride","aminoacridine","9-Acridinamine monohydrochloride","9-Aminoacridine monohydrochloride","NSC-7571","aminacrine","9-Aminoacridine","aminacrin","izoacridina","monacrin","aminacrine HCl"],"timeline":[],"brandName":"Monacrin","ecosystem":[],"mechanism":{"target":"Ribosyldihydronicotinamide dehydrogenase [quinone], Amine oxidase [flavin-containing] A, Trypanothione reductase","targets":[{"gene":"NQO2","source":"DrugCentral","target":"Ribosyldihydronicotinamide dehydrogenase [quinone]","protein":"Ribosyldihydronicotinamide dehydrogenase [quinone]"},{"gene":"MAOA","source":"DrugCentral","target":"Amine oxidase [flavin-containing] A","protein":"Amine oxidase [flavin-containing] A"}],"modality":"Small Molecule","drugClass":"aminoacridine","explanation":"Think of it like a car engine: Ribosyldihydronicotinamide dehydrogenase [quinone] is like the fuel pump that helps generate energy for the cell. Monacrin is like a brake that slows down the fuel pump, reducing the cell's energy production. This can be beneficial in certain situations, but it also means the cell may not be able to function properly.","oneSentence":"Monacrin works by inhibiting the activity of Ribosyldihydronicotinamide dehydrogenase [quinone], an enzyme that plays a crucial role in cellular energy production.","technicalDetail":"Monacrin binds to the active site of Ribosyldihydronicotinamide dehydrogenase [quinone], preventing the enzyme from accepting its substrate and thereby inhibiting its activity."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/160","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=aminoacridine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=aminoacridine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:40:51.471582","biosimilars":[],"competitors":[{"drugName":"binimetinib","drugSlug":"binimetinib","fdaApproval":"2018-06-27","patentExpiry":"Oct 18, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"chloroquine","drugSlug":"chloroquine","fdaApproval":"1949-10-31","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"dabigatran etexilate","drugSlug":"dabigatran-etexilate","fdaApproval":"2010-10-19","patentExpiry":"Mar 7, 2026","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"fedratinib","drugSlug":"fedratinib","fdaApproval":"2019-08-16","patentExpiry":"Sep 24, 2039","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"gilteritinib","drugSlug":"gilteritinib","fdaApproval":"2018-11-28","patentExpiry":"Nov 28, 2032","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"imatinib","drugSlug":"imatinib","fdaApproval":"2001-05-10","patentExpiry":"Apr 27, 2040","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"lenvatinib","drugSlug":"lenvatinib","fdaApproval":"2015-02-13","patentExpiry":"Sep 3, 2036","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"melatonin","drugSlug":"melatonin","fdaApproval":"","relationship":"same-target"},{"drugName":"nilotinib","drugSlug":"nilotinib","fdaApproval":"2007-10-29","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"osimertinib","drugSlug":"osimertinib","fdaApproval":"2015-11-13","patentExpiry":"Nov 26, 2042","patentStatus":"Patent protected","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"aminoacridine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"_fixedFields":["pubmed(1015)"],"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"binimetinib","brandName":"binimetinib","genericName":"binimetinib","approvalYear":"2018","relationship":"same-target"},{"drugId":"chloroquine","brandName":"chloroquine","genericName":"chloroquine","approvalYear":"1949","relationship":"same-target"},{"drugId":"dabigatran-etexilate","brandName":"dabigatran etexilate","genericName":"dabigatran etexilate","approvalYear":"2010","relationship":"same-target"},{"drugId":"fedratinib","brandName":"fedratinib","genericName":"fedratinib","approvalYear":"2019","relationship":"same-target"},{"drugId":"gilteritinib","brandName":"gilteritinib","genericName":"gilteritinib","approvalYear":"2018","relationship":"same-target"},{"drugId":"imatinib","brandName":"imatinib","genericName":"imatinib","approvalYear":"2001","relationship":"same-target"},{"drugId":"lenvatinib","brandName":"lenvatinib","genericName":"lenvatinib","approvalYear":"2015","relationship":"same-target"},{"drugId":"melatonin","brandName":"melatonin","genericName":"melatonin","approvalYear":"","relationship":"same-target"},{"drugId":"nilotinib","brandName":"nilotinib","genericName":"nilotinib","approvalYear":"2007","relationship":"same-target"},{"drugId":"osimertinib","brandName":"osimertinib","genericName":"osimertinib","approvalYear":"2015","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07464665","phase":"NA","title":"Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Approach","status":"NOT_YET_RECRUITING","sponsor":"Elsan","startDate":"2026-06-01","conditions":["Primary Total Hip Arthroplasty","Primary Total Hip Replacement"],"enrollment":300,"completionDate":"2030-06-01"},{"nctId":"NCT06435286","phase":"PHASE2","title":"Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2025-02-17","conditions":["Suspected or Known Squamous Cell Neoplasia","Prior History of Squamous Cell Dysplasia and /or Neoplasia"],"enrollment":200,"completionDate":"2027-03-01"},{"nctId":"NCT05554133","phase":"NA","title":"Precision Optical Guidance for Oral Biopsy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-06-15","conditions":["Oral Lesions"],"enrollment":90,"completionDate":"2027-03-31"},{"nctId":"NCT01269190","phase":"NA","title":"Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-12-30","conditions":["Oral Cavity Neoplasm"],"enrollment":275,"completionDate":"2028-12-31"},{"nctId":"NCT02790853","phase":"EARLY_PHASE1","title":"Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-05-25","conditions":["Dysplasia","Lip and Oral Cavity Carcinoma","Oral Disorder","Premalignant Lesion"],"enrollment":63,"completionDate":"2026-05-31"},{"nctId":"NCT04563754","phase":"PHASE1,PHASE2","title":"The Effectiveness of High Resolution Microendoscopy for People Living With HIV","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2019-07-30","conditions":["Anal High Grade Squamous Intraepithelial Lesion"],"enrollment":163,"completionDate":"2025-03-28"},{"nctId":"NCT03765541","phase":"PHASE3","title":"Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2020-01-13","conditions":["Relapsed or Refractory Acute Myeloid Leukemia"],"enrollment":73,"completionDate":"2024-05-31"},{"nctId":"NCT02714439","phase":"EARLY_PHASE1","title":"Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2016-10-25","conditions":["Malignant Neoplasms of Female Genital Organs"],"enrollment":157,"completionDate":"2024-02-09"},{"nctId":"NCT01228331","phase":"PHASE2,PHASE3","title":"Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2010-10","conditions":["Leukemia"],"enrollment":745,"completionDate":"2024-11-20"},{"nctId":"NCT06265662","phase":"NA","title":"A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in Thailand","status":"NOT_YET_RECRUITING","sponsor":"Chulalongkorn University","startDate":"2024-06","conditions":["Chronic Disease","Noncommunicable Diseases"],"enrollment":150,"completionDate":"2025-09"},{"nctId":"NCT05807932","phase":"PHASE1,PHASE2","title":"Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-06-26","conditions":["Myelodysplastic Syndromes","Secondary Acute Myeloid Leukemia","Chronic Myelomonocytic Leukemia"],"enrollment":38,"completionDate":"2028-01-30"},{"nctId":"NCT05892523","phase":"","title":"Influence of Spinal Deformity on THA","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-11-08","conditions":["THA"],"enrollment":80,"completionDate":"2025-01-01"},{"nctId":"NCT05677191","phase":"PHASE2","title":"PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-01-01","conditions":["Trochanteric Fractures"],"enrollment":40,"completionDate":"2024-12-31"},{"nctId":"NCT02206048","phase":"NA","title":"Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-10-02","conditions":["Cervix Carcinoma"],"enrollment":9,"completionDate":"2021-04-21"},{"nctId":"NCT05416463","phase":"NA","title":"Clinical Study and Economic Analysis of an Intraoperative Navigation System for Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Grand River Hospital","startDate":"2022-07","conditions":["Total Hip Arthroplasty"],"enrollment":190,"completionDate":"2024-12"},{"nctId":"NCT05396781","phase":"PHASE2","title":"Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening","status":"COMPLETED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2022-01-13","conditions":["Suspected or Known Squamous Cell Neoplasia","Prior History of Squamous Cell Dysplasia and /or Neoplasia"],"enrollment":41,"completionDate":"2022-01-20"},{"nctId":"NCT03379389","phase":"PHASE4","title":"Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis","status":"COMPLETED","sponsor":"Fundação Educacional Serra dos Órgãos","startDate":"2018-03-31","conditions":["Urinary Tract Infections"],"enrollment":284,"completionDate":"2021-06-01"},{"nctId":"NCT02420665","phase":"EARLY_PHASE1","title":"Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-23","conditions":["Cervical Cancer"],"enrollment":50,"completionDate":"2021-05-14"},{"nctId":"NCT01844076","phase":"PHASE1,PHASE2","title":"Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma","status":"TERMINATED","sponsor":"Fox Chase Cancer Center","startDate":"2016-01-14","conditions":["Colorectal Adenocarcinoma"],"enrollment":19,"completionDate":"2019-08-09"},{"nctId":"NCT02018367","phase":"PHASE2","title":"Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma","status":"UNKNOWN","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2012-09","conditions":["Barrett's Esophagus"],"enrollment":100,"completionDate":"2021-12"},{"nctId":"NCT02029937","phase":"PHASE2","title":"High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia","status":"UNKNOWN","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2014-01","conditions":["Suspected or Known Squamous Cell Neoplasia","Prior History of Squamous Cell Dysplasia and /or Neoplasia"],"enrollment":1300,"completionDate":"2021-12"},{"nctId":"NCT02405104","phase":"PHASE4","title":"Chlorzoxazone in Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"Northern Orthopaedic Division, Denmark","startDate":"2015-09-01","conditions":["Osteoarthritis of Hip","Osteoarthritis, Knee"],"enrollment":400,"completionDate":"2019-07-31"},{"nctId":"NCT03859791","phase":"","title":"\"True Incidence of Hip Dislocation After Primary THA - a Nationwide Population Study\"","status":"UNKNOWN","sponsor":"University of Southern Denmark","startDate":"2018-01-01","conditions":["Hip Dislocation"],"enrollment":32500,"completionDate":"2019-10-01"},{"nctId":"NCT01506024","phase":"NA","title":"Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2011-09","conditions":["Hip Osteoarthritis"],"enrollment":60,"completionDate":"2014-04"},{"nctId":"NCT01456143","phase":"NA","title":"Optical Imaging of Head and Neck Cancer","status":"TERMINATED","sponsor":"Sharmila Anandasabapathy, MD","startDate":"2011-12","conditions":["Squamous Cell Carcinoma","Neoplasia","Head and Neck Cancer"],"enrollment":33,"completionDate":"2014-07"},{"nctId":"NCT01839955","phase":"PHASE1","title":"Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Neelesh Sharma MD PhD","startDate":"2013-09","conditions":["Recurrent Non-small Cell Lung Cancer","Stage IIIB Non-small Cell Lung Cancer","Stage IV Non-small Cell Lung Cancer"],"enrollment":12,"completionDate":"2016-10"},{"nctId":"NCT01384227","phase":"EARLY_PHASE1","title":"Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study","status":"COMPLETED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2009-02","conditions":["Barrett's Esophagus"],"enrollment":40,"completionDate":""},{"nctId":"NCT01384695","phase":"EARLY_PHASE1","title":"A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1","status":"TERMINATED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2009-06","conditions":["GERD","Barrett's Esophagus"],"enrollment":67,"completionDate":"2014-02"},{"nctId":"NCT01384240","phase":"EARLY_PHASE1","title":"Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia","status":"TERMINATED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2010-04","conditions":["Colon Polyps","Colonic Dysplasia","Anal Dysplasia"],"enrollment":183,"completionDate":"2014-05"},{"nctId":"NCT01384708","phase":"EARLY_PHASE1","title":"Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer","status":"COMPLETED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2010-08","conditions":["Squamous Cell Cancer"],"enrollment":70,"completionDate":"2013-10"},{"nctId":"NCT01384864","phase":"EARLY_PHASE1","title":"Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia","status":"COMPLETED","sponsor":"Anandasabapathy, Sharmila, M.D.","startDate":"2011-08","conditions":["Barrett's Esophagus","Intraepithelial Neoplasia"],"enrollment":30,"completionDate":"2015-12"},{"nctId":"NCT00574483","phase":"PHASE2","title":"Treatment of Advanced Renal Cell Carcinoma With Quinacrine","status":"WITHDRAWN","sponsor":"Cleveland BioLabs","startDate":"2007-11","conditions":["Renal Cell Carcinoma"],"enrollment":0,"completionDate":"2008-01"},{"nctId":"NCT02095847","phase":"PHASE2","title":"High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"","conditions":["Uterine Cancer"],"enrollment":0,"completionDate":"2015-03"},{"nctId":"NCT00104663","phase":"NA","title":"PRION-1: Quinacrine for Human Prion Disease","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2004-06","conditions":["Prion Disease"],"enrollment":160,"completionDate":"2007-03"},{"nctId":"NCT00183092","phase":"PHASE2","title":"CJD (Creutzfeldt-Jakob Disease) Quinacrine Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2005-04","conditions":["Creutzfeldt-Jakob Disease"],"enrollment":69,"completionDate":"2012-06"},{"nctId":"NCT00002658","phase":"PHASE3","title":"Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia","status":"UNKNOWN","sponsor":"Medical Research Council","startDate":"1994-01","conditions":["Leukemia","Neutropenia"],"enrollment":2000,"completionDate":""},{"nctId":"NCT01406522","phase":"PHASE2","title":"Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics","status":"WITHDRAWN","sponsor":"Midwest Biomedical Research Foundation","startDate":"2012-10","conditions":["Cocaine Dependence"],"enrollment":0,"completionDate":"2013-11"},{"nctId":"NCT00003436","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"1998-07","conditions":["Leukemia","Myelodysplastic Syndromes"],"enrollment":2000,"completionDate":"2005-12"},{"nctId":"NCT00417274","phase":"PHASE2","title":"Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer","status":"COMPLETED","sponsor":"Cleveland BioLabs","startDate":"2006-12","conditions":["Prostatic Cancer"],"enrollment":31,"completionDate":"2008-05"},{"nctId":"NCT01324063","phase":"PHASE3","title":"A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1986-11","conditions":["Leukemia"],"enrollment":160,"completionDate":""},{"nctId":"NCT00002719","phase":"PHASE3","title":"Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1995-12","conditions":["Leukemia","Neutropenia"],"enrollment":500,"completionDate":""},{"nctId":"NCT01600313","phase":"NA","title":"Effect of Low Calorie Diet With Rice Bran Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients","status":"UNKNOWN","sponsor":"Qazvin University Of Medical Sciences","startDate":"2008-06","conditions":["Hyperlipidemias"],"enrollment":50,"completionDate":"2012-06"},{"nctId":"NCT00633256","phase":"NA","title":"The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2006-12","conditions":["Smoking"],"enrollment":20,"completionDate":"2008-02"},{"nctId":"NCT01348178","phase":"","title":"Retrospective Follow-up Study After Periacetabular Osteotomy in Adults","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2010-03","conditions":["Congenital Deformity of Hip Joints"],"enrollment":401,"completionDate":"2011-11"},{"nctId":"NCT01491048","phase":"NA","title":"Evaluation of Functional Rehabilitation in Patients Undergoing Physiotherapy After Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2009-07","conditions":["Osteoarthritis, Hip"],"enrollment":104,"completionDate":"2011-10"},{"nctId":"NCT00840684","phase":"PHASE1,PHASE2","title":"Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Institut Paoli-Calmettes","startDate":"2009-01","conditions":["Leukemia"],"enrollment":135,"completionDate":""},{"nctId":"NCT01052025","phase":"PHASE4","title":"Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance","status":"UNKNOWN","sponsor":"Srinakharinwirot University","startDate":"2009-08","conditions":["Type 2 Diabetes","Pre-diabetes","Insulin Resistance","Cardiovascular Risk"],"enrollment":200,"completionDate":"2010-04"},{"nctId":"NCT01052597","phase":"PHASE4","title":"Curcumin for Type 2 Diabetic Patients","status":"UNKNOWN","sponsor":"Srinakharinwirot University","startDate":"2009-07","conditions":["Type 2 Diabetes Mellitus","Cardiovascular Abnormalities"],"enrollment":200,"completionDate":"2010-03"},{"nctId":"NCT00949351","phase":"PHASE4","title":"Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy","status":"UNKNOWN","sponsor":"Lerdsin General Hospital","startDate":"2009-09","conditions":["Type 2 Diabetes With Nephropathy"],"enrollment":80,"completionDate":"2010-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NUI":"N0000179393","MMSL":"NOCODE","NDDF":"002960","UNII":"OR5RM3Q5QL","VUID":"4018614","CHEBI":"CHEBI:51803","VANDF":"4018614","INN_ID":"1476","RXNORM":"645","UMLSCUI":"C0002503","ChEMBL_ID":"CHEMBL43184","KEGG_DRUG":"D02905","DRUGBANK_ID":"DB11561","PDB_CHEM_ID":" AA ","PUBCHEM_CID":"7019","SNOMEDCT_US":"391756001","SECONDARY_CAS_RN":"134-50-9","MESH_DESCRIPTOR_UI":"D000585"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1015,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"D08AA02","allCodes":["D08AA02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 4","pmid":"41775803","title":"High-throughput screening of small molecule Wnt/β-catenin activators for hair and nail growth.","journal":"Communications biology"},{"date":"2026 Feb 8","pmid":"41545104","title":"MALDI mass spectrometry and imaging for lipid analysis in food matrices: A review of analytical principles and perspectives.","journal":"Analytica chimica acta"},{"date":"2026 Jan 21","pmid":"41508864","title":"Assessing the Multitarget Therapeutic Potential of Novel 9-Aminoacridine Derivatives for Alzheimer's Disease.","journal":"ACS chemical neuroscience"},{"date":"2025 Dec 6","pmid":"41440281","title":"Features of Chaperone Induction by 9-Aminoacridine and Acridine Orange.","journal":"Biosensors"},{"date":"2025 Nov 5","pmid":"41147643","title":"Investigating the Quantitative Structure-Ionization Efficiency Relationship of Small Molecules and Lipids in the Presence of Ammonium Fluoride in MALDI-TIMS-QTOF Mass Spectrometry Imaging.","journal":"Journal of the American Society for Mass Spectrometry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Monacrin is a small molecule with the synonym 9-Aminoacridine. It is one of several chemical compounds known as aminoacridines, which include 2-Aminoacridine, 3-Aminoacridine, and 4-Aminoacridine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}